Keyphrases
Response Monitoring
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Response to Treatment
100%
Tumor
75%
PET Imaging
75%
Non-responders
75%
Glucose Use
50%
Tumor Glucose Metabolism
50%
Clinical Significance
25%
Magnetic Resonance Imaging
25%
Molecular Targets
25%
Ultrasound
25%
Patient Outcomes
25%
High Reproducibility
25%
Cost Reduction
25%
Imaging Technology
25%
Functional Imaging
25%
Tumor Subtype
25%
Breast
25%
Tumor Cells
25%
Experimental Therapeutics
25%
Lymphoma
25%
Tumor Recurrence
25%
New Therapeutic Strategies
25%
Rapid Reduction
25%
Metabolic Activity
25%
Current Therapies
25%
Accurate Identification
25%
Effective Therapy
25%
Treatment Monitoring
25%
Therapy Regimen
25%
Phase II Study
25%
Recurrent Tumor
25%
Resectability
25%
Therapy Initiation
25%
Treatment Completion
25%
Head-and-neck
25%
Response to Therapy
25%
Therapeutic Response
25%
Surrogate Endpoint
25%
In Vivo Assessment
25%
Esophageal Lung
25%
Biologic Processes
25%
Residual Mass
25%
Therapeutic Modalities
25%
In Vivo Quantification
25%
Outcome Costs
25%
Targeted Cancer Therapy
25%
Viable Tumor
25%
Radiation Necrosis
25%
New Therapeutic Agents
25%
FDG-PET Scan
25%
Patient's Will
25%
Number of Patients
25%
Therapy Response Prediction
25%
Clinical Phases
25%
Treatment Regime
25%
First Treatment
25%
Medicine and Dentistry
Polyethylene Terephthalate
100%
Neoplasm
85%
Positron Emission Tomography
57%
Glucose Metabolism
28%
Tumor Recurrence
28%
Treatment Response
28%
Health Care Cost
14%
Reproducibility
14%
Neck
14%
Cancer
14%
Prospective Study
14%
Lung
14%
Functional Imaging
14%
Tumor Cell
14%
Experimental Therapy
14%
Therapeutic Agent
14%
Molecularly Targeted Therapy
14%
Radiation Necrosis
14%
Magnetic Resonance Imaging
14%